Pharmacokinetic Evaluation of Amphotericin B in Lung Tissue: Lung Lymph Distribution after Intravenous Injection and Airspace Distribution after Aerosolization and Inhalation of Amphotericin B
暂无分享,去创建一个
K. Kubo | M. Sekiguchi | Hiroshi Yamamoto | M. Hanaoka | T. Koizumi | K. Fujimoto | Toshio Kobayashi | T. Hayano | T. Kaneki | Takayuki Miyahara | Kazuyoshi Okada
[1] R. Durand,et al. Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model , 1997, Antimicrobial agents and chemotherapy.
[2] E. Anaissie,et al. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. , 1995, Blood.
[3] D. Huhn,et al. Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis , 1993, Antimicrobial Agents and Chemotherapy.
[4] K. Kubo,et al. Pharmacokinetic Evaluation of (Glycolato‐O, O′) diammine Platinum(II) in Lung Lymph in Sheep , 1993, Japanese journal of cancer research : Gann.
[5] K. Kubo,et al. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep. , 1992, Journal of applied physiology.
[6] S. McCann,et al. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. , 1990, Bone marrow transplantation.
[7] D. Armstrong,et al. Pharmacokinetics of aerosol amphotericin B in rats , 1990, Antimicrobial Agents and Chemotherapy.
[8] R. Pazdur,et al. Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients. , 1989, Journal of pharmaceutical sciences.
[9] F. Meunier,et al. Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate , 1989, Antimicrobial Agents and Chemotherapy.
[10] M. Matthay,et al. Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. , 1988, The Journal of clinical investigation.
[11] J. Newman,et al. Effect of progressive exercise on lung fluid balance in sheep. , 1988, Journal of applied physiology.
[12] J. Wiener-Kronish,et al. Removal of pleural liquid and protein by lymphatics in awake sheep. , 1988, Journal of applied physiology.
[13] D. Schlessinger,et al. Interaction of plasma proteins and lipoproteins with amphotericin B. , 1984, The Journal of infectious diseases.
[14] G. Medoff,et al. Strategies in the treatment of systemic fungal infections. , 1980, The New England journal of medicine.
[15] K. Brigham,et al. Increased Sheep Lung Vascular Permeability Caused by Escherichia coli Endotoxin , 1979, Circulation research.
[16] K. Brigham,et al. Preparation of chronic lung lymph fistulas in sheep. , 1975, Journal of Surgical Research.
[17] E. Block,et al. Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. , 1974, Annals of internal medicine.
[18] J. Bennett. Chemotherapy of systemic mycoses (first of two parts). , 1974, The New England journal of medicine.
[19] B. T. Fields,et al. Amphotericin B serum concentrations during therapy. , 1970, Applied microbiology.
[20] J. Bennett,et al. A pharmacologic guide to the clinical use of amphotericin B. , 1969, The Journal of infectious diseases.